Nestin mRNA 3'-untranslated region (NES mRNA 3'-UTR) (NES mRNA 3'-UTR)

The Nestin mRNA 3'-untranslated region (3'-UTR) is a critical regulatory sequence of the Nestin (NES) transcript, which encodes a type VI intermediate filament protein (UniProt: P48681). Nestin is a well-established marker for neural stem cells and is highly expressed during embryonic development, but its expression is typically downregulated in adult tissues (PubMed: 15189133). In various malignancies, including glioblastoma, melanoma, and breast cancer, Nestin is re-expressed and serves as a marker for cancer stem cells, correlating with aggressive tumor behavior and poor patient prognosis (PubMed: 23536430). The 3'-UTR of Nestin mRNA contains multiple binding sites for microRNAs such as miR-124, miR-9, and miR-429, which post-transcriptionally regulate its expression (PubMed: 21135165, 25600157). These microRNAs bind to the 3'-UTR to induce mRNA degradation or translational repression, effectively controlling the protein output of the NES gene. Therapeutic targeting of this region using miRNA mimics or antisense oligonucleotides aims to reduce Nestin levels, thereby inhibiting tumor cell proliferation, migration, and stemness (PubMed: 24333725). Beyond oncology, Nestin regulation is also studied in the context of regenerative medicine and neurodegenerative diseases where stem cell niche maintenance is vital. Challenges in targeting the Nestin mRNA 3'-UTR include ensuring specificity to avoid off-target effects and achieving efficient delivery to target tissues, particularly across the blood-brain barrier for CNS tumors.

Other names

NES 3'-UTRNestin 3'-UTRNestin 3'-untranslated regionNES mRNA regulatory region

Post-transcriptional gene silencing via RNA interference (RNAi) or antisense-mediated inhibition, where therapeutic agents bind to the 3'-untranslated region to trigger mRNA degradation or block translation.